Strasbourg, France

Miloud Benchaïbi

This inventor holds 1 USPTO granted patent. Top assignee: Merial Limited. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miloud Benchaïbi: Innovator in Avian Cell Technology

Introduction

Miloud Benchaïbi is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of immortalized avian cell lines. His work has implications for various applications in research and industry.

Latest Patents

Miloud holds a patent for "Immortalized avian cell lines." This invention features non-transformant immortal avian cells, specifically derived from avian tissues, excluding blood or hematopoietic cells. The cells, particularly fibroblasts and epithelial cells from embryos, are immortalized using the SV40 T+t gene under the control of the MTI promoter. They integrate the pDAMT vector, showcasing a novel approach to avian cell line development.

Career Highlights

Miloud Benchaïbi is currently associated with Merial Limited, a company known for its advancements in animal health. His expertise in avian cell technology has positioned him as a key figure in the field, contributing to innovative solutions that enhance research capabilities.

Collaborations

Miloud has collaborated with esteemed colleagues such as Philippe Desmettre and Jean-François Bouquet. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biotechnology.

Conclusion

Miloud Benchaïbi's work in immortalized avian cell lines represents a significant advancement in biotechnology. His contributions continue to influence research and development in the field, highlighting the importance of innovation in scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…